Angiotech to participate in CIBC 18th Annual Healthcare Conference
30 Oktober 2007 - 9:15PM
PR Newswire (US)
VANCOUVER, Oct. 30 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global
specialty pharmaceutical and medical device company, is scheduled
to participate in the CIBC 18th Annual Healthcare Conference, which
is being held November 5 - 7 in New York City. Tom Bailey,
Angiotech Chief Financial Officer, will make a 30-minute
presentation followed by a 30-minute break-out session on Monday,
November 5, beginning at approximately 3:05pm ET. A live webcast of
Mr. Bailey's remarks will be available to all interested parties at
Angiotech's website, http://www.angiotech.com/, in the Investors
section. To ensure a timely connection to the webcast it is
recommended that users register at least 15 minutes before the
webcast begins. The webcast will be archived approximately three
hours after the live event and will be available for 90 days
through February 5, 2008. About Angiotech Angiotech
Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company with over 1,500 dedicated employees.
Angiotech discovers, develops and markets innovative treatment
solutions for diseases or complications associated with medical
device implants, surgical interventions and acute injury. To find
out more about Angiotech (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please
visit our website at http://www.angiotech.com/. CONTACT: Deirdre
Neary, Manager, Investor Relations, Angiotech Pharmaceuticals Inc.,
(604) 222-7056, DATASOURCE: Angiotech Pharmaceuticals, Inc.
CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech
Pharmaceuticals Inc., (604) 222-7056,
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel